Literature DB >> 21182989

Vitamin B(6) salvage enzymes: mechanism, structure and regulation.

Martino Luigi di Salvo1, Roberto Contestabile, Martin K Safo.   

Abstract

Vitamin B(6) is a generic term referring to pyridoxine, pyridoxamine, pyridoxal and their related phosphorylated forms. Pyridoxal 5'-phosphate is the catalytically active form of vitamin B(6), and acts as cofactor in more than 140 different enzyme reactions. In animals, pyridoxal 5'-phosphate is recycled from food and from degraded B(6)-enzymes in a "salvage pathway", which essentially involves two ubiquitous enzymes: an ATP-dependent pyridoxal kinase and an FMN-dependent pyridoxine 5'-phosphate oxidase. Once it is made, pyridoxal 5'-phosphate is targeted to the dozens of different apo-B(6) enzymes that are being synthesized in the cell. The mechanism and regulation of the salvage pathway and the mechanism of addition of pyridoxal 5'-phosphate to the apo-B(6)-enzymes are poorly understood and represent a very challenging research field. Pyridoxal kinase and pyridoxine 5'-phosphate oxidase play kinetic roles in regulating the level of pyridoxal 5'-phosphate formation. Deficiency of pyridoxal 5'-phosphate due to inborn defects of these enzymes seems to be involved in several neurological pathologies. In addition, inhibition of pyridoxal kinase activity by several pharmaceutical and natural compounds is known to lead to pyridoxal 5'-phosphate deficiency. Understanding the exact role of vitamin B(6) in these pathologies requires a better knowledge on the metabolism and homeostasis of the vitamin. This article summarizes the current knowledge on structural, kinetic and regulation features of the two enzymes involved in the PLP salvage pathway. We also discuss the proposal that newly formed PLP may be transferred from either enzyme to apo-B(6)-enzymes by direct channeling, an efficient, exclusive, and protected means of delivery of the highly reactive PLP. This new perspective may lead to novel and interesting findings, as well as serve as a model system for the study of macromolecular channeling. This article is part of a Special Issue entitled: Pyridoxal Phosphate Enzymology.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21182989     DOI: 10.1016/j.bbapap.2010.12.006

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  55 in total

1.  Open conformation of human DOPA decarboxylase reveals the mechanism of PLP addition to Group II decarboxylases.

Authors:  Giorgio Giardina; Riccardo Montioli; Stefano Gianni; Barbara Cellini; Alessandro Paiardini; Carla Borri Voltattorni; Francesca Cutruzzolà
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-05       Impact factor: 11.205

2.  Pyridoxal Reductase, PdxI, Is Critical for Salvage of Pyridoxal in Escherichia coli.

Authors:  Tomokazu Ito; Diana M Downs
Journal:  J Bacteriol       Date:  2020-05-27       Impact factor: 3.490

3.  Allosteric feedback inhibition of pyridoxine 5'-phosphate oxidase from Escherichia coli.

Authors:  Anna Barile; Angela Tramonti; Martino Luigi di Salvo; Isabel Nogués; Caterina Nardella; Francesco Malatesta; Roberto Contestabile
Journal:  J Biol Chem       Date:  2019-09-04       Impact factor: 5.157

Review 4.  Homocysteine-lowering interventions for preventing cardiovascular events.

Authors:  Arturo J Martí-Carvajal; Ivan Solà; Dimitrios Lathyris; Mark Dayer
Journal:  Cochrane Database Syst Rev       Date:  2017-08-17

Review 5.  Pharmacological tools for hydrogen sulphide research: a brief, introductory guide for beginners.

Authors:  Andreas Papapetropoulos; Matthew Whiteman; Giuseppe Cirino
Journal:  Br J Pharmacol       Date:  2014-09-05       Impact factor: 8.739

6.  Congenic dissection of a major QTL for methamphetamine sensitivity implicates epistasis.

Authors:  C D Bryant; L A Kole; M A Guido; G Sokoloff; A A Palmer
Journal:  Genes Brain Behav       Date:  2012-05-02       Impact factor: 3.449

7.  Normal Cerebrospinal Fluid Pyridoxal 5'-Phosphate Level in a PNPO-Deficient Patient with Neonatal-Onset Epileptic Encephalopathy.

Authors:  Alina Levtova; Stephane Camuzeaux; Anne-Marie Laberge; Pierre Allard; Catherine Brunel-Guitton; Paola Diadori; Elsa Rossignol; Keith Hyland; Peter T Clayton; Philippa B Mills; Grant A Mitchell
Journal:  JIMD Rep       Date:  2015-03-12

8.  Pyridoxine responsiveness in novel mutations of the PNPO gene.

Authors:  Barbara Plecko; Karl Paul; Philippa Mills; Peter Clayton; Eduard Paschke; Oliver Maier; Oswald Hasselmann; Gudrun Schmiedel; Simone Kanz; Mary Connolly; Nicole Wolf; Eduard Struys; Sylvia Stockler; Lucia Abela; Doris Hofer
Journal:  Neurology       Date:  2014-03-21       Impact factor: 9.910

Review 9.  Intracellular trafficking of the pyridoxal cofactor. Implications for health and metabolic disease.

Authors:  James W Whittaker
Journal:  Arch Biochem Biophys       Date:  2015-11-24       Impact factor: 4.013

10.  Correlation between the molecular effects of mutations at the dimer interface of alanine-glyoxylate aminotransferase leading to primary hyperoxaluria type I and the cellular response to vitamin B6.

Authors:  Mirco Dindo; Elisa Oppici; Daniele Dell'Orco; Rosa Montone; Barbara Cellini
Journal:  J Inherit Metab Dis       Date:  2017-11-06       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.